000 01504 a2200409 4500
005 20250517202826.0
264 0 _c20190708
008 201907s 0 0 eng d
022 _a1096-7206
024 7 _a10.1016/j.ymgme.2018.02.006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHarmatz, Paul
245 0 0 _aA novel Blind Start study design to investigate vestronidase alfa for mucopolysaccharidosis VII, an ultra-rare genetic disease.
_h[electronic resource]
260 _bMolecular genetics and metabolism
_c04 2018
300 _a488-494 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aChild
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aGlucuronidase
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMucopolysaccharidosis VII
_xenzymology
650 0 4 _aPrognosis
650 0 4 _aRecombinant Proteins
_xadministration & dosage
650 0 4 _aYoung Adult
700 1 _aWhitley, Chester B
700 1 _aWang, Raymond Y
700 1 _aBauer, Mislen
700 1 _aSong, Wenjie
700 1 _aHaller, Christine
700 1 _aKakkis, Emil
773 0 _tMolecular genetics and metabolism
_gvol. 123
_gno. 4
_gp. 488-494
856 4 0 _uhttps://doi.org/10.1016/j.ymgme.2018.02.006
_zAvailable from publisher's website
999 _c28120535
_d28120535